Y-Intercept »

Connect Biopharma Hldgs shares owned by Y-Intercept

Quarter-by-quarter ownership of Connect Biopharma Hldgs (CNTB) shares owned by Y-Intercept from 13F filings

Historical chart of Y-Intercept investment in Connect Biopharma Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Connect Biopharma Hldgs held by Y-Intercept consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Connect Biopharma Hldgs by Y-Intercept

Quarter filed Position value Share count Share price at filing
2026-06-30 $36k 15k 2.38

More positions owned by Y-Intercept

Amazon (AMZN)
Apple (AAPL)
Boston Scientific Corporation (BSX)
Microsoft Corporation (MSFT)
Space Exploration Techn Corp Class A Com Stk (SPCX)
salesforce (CRM)
Cme (CME)
Cognizant Technology Solutio Cl A (CTSH)
Intuit (INTU)
Qualcomm (QCOM)
CBOE Holdings (CBOE)
NVIDIA Corporation (NVDA)
Accenture Plc Ireland Shs Class A (ACN)
Monolithic Power Systems (MPWR)
JPMorgan Chase & Co. (JPM)

View all positions for Y-Intercept

Top funds holding Connect Biopharma Hldgs

Ikarian Capital
683 Capital Management
Boothbay Fund Management
BlackRock
Perceptive Advisors
ADAR1 Capital Management
BML Capital Management
Silverarc Capital Management
Richmond Brothers
Knott David M Jr
Stonepine Capital Management
Marshall Wace
Geode Capital Management
Two Sigma Investments
Diadema Partners

View all funds holding Connect Biopharma Hldgs